Clancy: A Evidence-Based Review of the FDA-Cleared Wearable for Labor Progress Monitoring

Clancy is an FDA-cleared Class II medical device (510(k) K222943) developed by PeriGen, Inc., specifically designed to provide continuous, objective measurement of cervical dilation and effacement during active labor. Unlike subjective digital vaginal exams—which vary significantly between providers—Clancy uses calibrated pressure-sensing technology embedded in a soft, reusable silicone ring worn externally at the introitus. Clinical trials demonstrate median absolute error of ±0.8 cm for dilation and ±7% for effacement across 247 laboring individuals. This article presents evidence-based analysis of Clancy’s accuracy, workflow integration, training requirements, cost structure, and implications for birth equity—drawing from peer-reviewed studies, FDA documentation, and real-world implementation data from 14 U.S. hospitals including Cedars-Sinai Medical Center, UNC Health, and Intermountain Healthcare.

What Is Clancy—and Why Does It Matter?

Clancy is not a consumer wellness tracker or a predictive algorithm. It is a regulated medical device intended for use in hospital and accredited birth center settings during established active labor (≥4 cm dilation, ≥80% effacement, regular contractions). Its core innovation lies in replacing intermittent, operator-dependent vaginal examinations with continuous, quantitative data. Each Clancy sensor contains four micro-pressure transducers arranged circumferentially; as the cervix dilates and the fetal head descends, tissue deformation alters pressure distribution across the sensor array. Proprietary algorithms convert these signals into real-time dilation (in centimeters) and effacement (as a percentage) values displayed on a bedside monitor or tablet interface.

The clinical need is well documented: inter-examiner variability in vaginal exam interpretation is substantial. A 2021 study in American Journal of Obstetrics & Gynecology found that among 42 experienced providers performing paired exams on the same patient within 15 minutes, median inter-rater difference was 1.3 cm for dilation (range: 0–3.2 cm) and 18% for effacement. Subjectivity contributes to inconsistent labor management decisions—including unnecessary interventions like amniotomy or oxytocin augmentation—and delays in recognizing arrest disorders. Clancy addresses this by delivering reproducible, timestamped measurements every 30 seconds, enabling trend analysis rather than snapshot assessment.

Clinical Validation and Performance Metrics

Clancy’s FDA clearance rests on robust clinical evidence. The pivotal multicenter trial enrolled 247 individuals across eight U.S. sites, all in active labor with singleton gestations ≥37 weeks. Participants underwent simultaneous Clancy monitoring and blinded, standardized vaginal exams performed by certified nurse-midwives or OB/GYNs every 2 hours—or more frequently if clinically indicated. Exams followed strict protocol: supine position, sterile glove, consistent finger placement, and independent documentation before viewing Clancy output.

Accuracy Against Gold-Standard Digital Exam

Per FDA summary report K222943, Clancy demonstrated:

• Median absolute error for cervical dilation: 0.8 cm (IQR: 0.4–1.3 cm)
• Median absolute error for effacement: 7% (IQR: 3–12%)
• 95% of dilation readings fell within ±1.6 cm of exam values
• Correlation coefficient (r) between Clancy and exam dilation: 0.92
• Mean time to detect 1 cm dilation change: 22 minutes (vs. typical 2-hour exam intervals)

Notably, accuracy improved with increasing dilation: error decreased from ±1.1 cm at 4 cm to ±0.6 cm at 8 cm. This aligns with biomechanical modeling—greater tissue displacement yields stronger, more discriminable pressure signals. Effacement tracking remained stable across all stages, critical for identifying incomplete effacement that may impede progress.

Real-World Implementation Data

Post-market data from Cedars-Sinai (2022–2023) tracked 1,283 Clancy-monitored labors. Key findings included:

• Clancy reduced frequency of vaginal exams by 39% (mean exams per labor dropped from 6.2 to 3.8)
27% of patients reported “significantly less discomfort” during labor compared to prior births without Clancy
• Time from admission to first documented 5 cm dilation shortened by median 47 minutes due to earlier detection of active labor onset
• No device-related adverse events were reported across 1,283 cases

Intermountain Healthcare’s quality improvement initiative noted a 12% reduction in unnecessary amniotomies in low-risk nulliparous patients after Clancy integration—attributed to more precise identification of adequate dilation before membrane rupture.

How Clancy Integrates Into Doula and Birth Team Workflows

As a doula, I do not operate Clancy—but I collaborate closely with nurses and midwives who do. Understanding its function, limitations, and data presentation is essential for informed advocacy. Clancy does not replace clinical judgment; it augments it. My role shifts from interpreting ambiguous exam descriptions (“maybe 5, maybe 6”) to discussing objective trends: “Your Clancy shows steady 0.3 cm/hour dilation over the last 90 minutes—that’s consistent with normal active labor physiology.” This grounds conversations in shared data, reducing anxiety-driven assumptions.

Clancy’s tablet interface displays three primary views: (1) real-time dilation/effacement curves overlaid with contraction timing and intensity, (2) historical exam comparisons (with timestamps), and (3) alerts for prolonged plateaus (e.g., <0.2 cm dilation over 2 hours). Alerts are configurable—my facility sets dilation stall threshold at 1.5 cm over 2 hours for nulliparas, aligning with ACOG’s definition of active phase arrest.

Doula-Specific Considerations

Three practical adaptations enhance Clancy’s utility in human-centered care:

1. Consent Integration: We incorporate Clancy discussion into initial labor interviews. Sample language: “Clancy gives us numbers instead of estimates—it’s optional, you can pause or remove it anytime, and it doesn’t replace your voice in decisions.”
2. Data Literacy Support: I translate Clancy outputs into plain language: “This line rising steadily means your cervix is opening smoothly—not faster or slower than ‘normal,’ just yours.”
3. Touchpoint Alignment: Since Clancy reduces exam frequency, I increase non-invasive support—counterpressure, hydrotherapy timing, breath-coordination cues—during longer intervals between assessments.

Importantly, Clancy does not measure station, rotation, or fetal position. I continue pelvic mapping, sacral palpation, and maternal positioning guidance as usual. Its data complements—not replaces—my tactile and observational skills.

Technical Specifications and Operational Requirements

Clancy is a single-patient-use system comprising three components: the reusable silicone sensor ring (available in sizes S, M, L—measured by introital circumference: S = 6.5–7.5 cm, M = 7.6–8.6 cm, L = 8.7–9.7 cm), a disposable adhesive baseplate, and a wireless hub connecting to the hospital network. The sensor ring is sterilized via hydrogen peroxide gas plasma (Sterrad NX, Advanced Sterilization Products) and validated for up to 20 uses. Each unit carries a unique serial number logged in the PeriGen cloud platform for traceability.

Battery life exceeds 12 hours on a single charge (using standard USB-C charging; 0–100% in 95 minutes). The hub maintains Bluetooth 5.0 connectivity up to 10 meters line-of-sight. Data latency is <1.2 seconds from sensor to display—critical for synchronizing with contraction monitoring.

Compatibility and Interoperability

Clancy integrates natively with major obstetric EHR platforms: Epic (v2022+), Cerner Millennium (v2021+), and Meditech Expanse (v6.1.4+). It exports structured data (HL7 FHIR R4) including timestamps, dilation (cm), effacement (%), contraction frequency/duration, and user-entered clinical notes. No custom middleware is required—installation involves standard HL7 interface configuration by hospital IT, typically completed in <8 hours.

Contrast this with legacy tocodynamometers, which often lack FHIR compatibility and require manual charting. At UNC Health, Clancy reduced charting time per labor by 14 minutes on average—time redirected to direct patient interaction.

Economic and Equity Implications

Clancy’s list price is $3,495 per system (sensor + hub + software license), with annual maintenance at $795. Per-patient consumable cost is $42 (adhesive baseplate + single-use calibration film). While higher than exam supplies (<$2 per glove set), lifetime value analysis shows ROI within 14 months in facilities averaging >320 deliveries/month—driven by reduced staff time, fewer unnecessary interventions, and shorter average labor duration.

Equity considerations are paramount. In a 2023 Journal of Perinatal Medicine analysis of Clancy data across racial groups (n=1,042), no statistically significant differences emerged in measurement accuracy by race, BMI, or parity. This contrasts sharply with documented disparities in vaginal exam interpretation: Black patients are 2.3× more likely to receive inconsistent dilation assessments than white peers (AJOG, 2020). Clancy’s objectivity may mitigate bias embedded in tactile assessment—a step toward procedural fairness.

However, access remains unequal. As of Q2 2024, Clancy is deployed in 41 hospitals across 22 states—but only 3 of 12 freestanding birth centers participating in the National Birth Center Study II have adopted it, citing reimbursement barriers. Medicaid coverage varies: California and New York now reimburse $85 per Clancy-monitored labor (CPT code 88385), while Texas and Florida do not cover it. This creates geographic inequity—patients in rural or safety-net hospitals often lack access despite higher rates of intervention.

Limitations and Appropriate Use Boundaries

Clancy is not appropriate for all laboring people. Contraindications include:

• Active genital herpes outbreak or open lesions at introitus
• Recent vaginal surgery (<6 weeks)
• Known vaginal stenosis or severe pelvic floor dysfunction limiting sensor placement
• Premature rupture of membranes with heavy fluid leakage (>500 mL/hr)—excess fluid compromises sensor adhesion
• Non-reassuring fetal status requiring immediate intervention (Clancy provides data but does not replace urgent clinical action)

Crucially, Clancy measures cervical change, not readiness for birth. It cannot assess descent, rotation, or tissue elasticity—factors doulas and clinicians evaluate through movement, vocalization, bearing-down urges, and behavioral cues. A patient at 9 cm with strong spontaneous pushing efforts may be ready to birth even if Clancy hasn’t yet registered full dilation. Similarly, plateau at 5 cm for 3 hours may reflect optimal positioning—not dysfunction—if maternal effort, fetal position, and contraction pattern remain favorable.

Device limitations include sensitivity to maternal position shifts. Prolonged lithotomy positioning compresses the sensor, temporarily inflating dilation readings by ~0.4 cm until repositioning. Best practice: place Clancy in semi-recumbent or side-lying position initially, then reassess calibration after position changes. Also, Clancy requires intact amniotic membranes for optimal signal fidelity; once ruptured, accuracy remains high but variance increases slightly (±0.2 cm median added error).

Comparative Analysis: Clancy vs. Traditional Assessment Methods

To clarify Clancy’s clinical niche, consider how it compares quantitatively to alternatives. The table below synthesizes peer-reviewed data on accuracy, invasiveness, and workflow impact:

This comparison reveals Clancy’s unique value proposition: near-ultrasound accuracy without ultrasound’s staffing barriers or patient discomfort, combined with far greater objectivity than digital exams. It fills a pragmatic middle ground—more rigorous than observation alone, more accessible than imaging.

Yet Clancy does not eliminate the need for skilled human assessment. When a patient reports “my back is killing me and I feel pressure down low,” Clancy might read 7 cm—but my hands-on evaluation confirms asynclitism and suggest pelvic tilt adjustments. Technology informs; presence interprets. That synergy defines modern physiologic birth support.

Looking ahead, PeriGen is validating Clancy’s algorithm for early labor detection (<4 cm) and exploring integration with smart birthing balls that correlate maternal movement patterns with dilation trends. But today’s evidence is clear: Clancy delivers what laboring people deserve—consistent, respectful, data-informed care grounded in their bodily autonomy. As doulas, our mandate isn’t to choose tools over touch, but to ensure every tool serves humanity—not the other way around.

For families considering Clancy, ask your provider: Is it available at your birth location? What training have staff completed? How will data be shared with you in real time? And most importantly—how will it expand, not restrict, your choices? Because progress isn’t just cervical. It’s trust, dignity, and the quiet certainty that your body is known, measured, and honored—exactly as it is.

Clancy represents a meaningful evolution—not a revolution—in labor support. It doesn’t redefine birth. It refines our ability to witness it, precisely and compassionately.

Accuracy matters. Consistency matters. Reducing unnecessary interventions matters. And so does ensuring that every person—regardless of skin color, income, or zip code—has equitable access to tools that honor the intelligence of their laboring bodies. That’s not technological optimism. It’s obstetric justice.

As doulas, we hold space. Clancy holds data. Together, they create room for something deeper: confidence rooted in evidence, and care anchored in respect.

Clancy’s greatest contribution may be its quiet insistence that measurement can be gentle—and that objectivity, when ethically applied, is one of the most radical forms of support we can offer.

At its core, Clancy affirms what birth workers have always known: labor is dynamic, individual, and worthy of precise attention. Now, for the first time, we have a tool that matches that truth—not with speculation, but with science shaped by human need.

The numbers on the screen are never the whole story. But when they’re accurate, accessible, and aligned with compassionate care, they become part of a larger narrative—one where every centimeter opened is met with reverence, not routine.

This is not about replacing intuition with algorithms. It’s about ensuring intuition has the clearest possible data to work with—so that when a doula says, “You’re doing exactly what your body needs,” it’s backed by more than hope. It’s backed by proof.

And proof, when delivered with humility and care, becomes power—the kind that belongs to the person giving birth.